Conference

Nine drugs denied to Irish patients due to price pressures

lifesci

Irish patients are being denied access to nine drugs that are widely available across Europe, largely on cost grounds. A new bulletin published by the Irish Pharmaceutical Healthcare Association (IPHA) has found that nine medicines currently in the Irish reimbursement system are already available in 12 other western European countries on average.

Cancer and cardiovascular care are the main areas where Ireland is lagging behind, according to the IPHA. This initial report says that seven new therapies have been approved by the State so far this year.

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free